0001493152-20-016390.txt : 20200820 0001493152-20-016390.hdr.sgml : 20200820 20200820104409 ACCESSION NUMBER: 0001493152-20-016390 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200812 FILED AS OF DATE: 20200820 DATE AS OF CHANGE: 20200820 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEINGARTEN ROBERT N CENTRAL INDEX KEY: 0001135337 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51476 FILM NUMBER: 201119168 MAIL ADDRESS: STREET 1: 5439 LOCKHURST DRIVE CITY: WOODLAND HILLS STATE: CA ZIP: 91367 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: LIXTE BIOTECHNOLOGY HOLDINGS, INC. CENTRAL INDEX KEY: 0001335105 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 202903526 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 BUSINESS PHONE: 310 203 2902 MAIL ADDRESS: STREET 1: 248 ROUTE 25A STREET 2: NO. 2 CITY: EAST SETAUKET STATE: NY ZIP: 11733 FORMER COMPANY: FORMER CONFORMED NAME: SRKP 7 INC DATE OF NAME CHANGE: 20050803 3 1 ownership.xml X0206 3 2020-08-12 0 0001335105 LIXTE BIOTECHNOLOGY HOLDINGS, INC. LIXT.OB 0001135337 WEINGARTEN ROBERT N 248 ROUTE 25A, NO. 2 EAST SETAUKET NY 11733 0 1 0 0 Vice President and CFO Options to Purchase Common Stock 1.19 2020-08-12 2025-08-12 Common Stock 87500 D The Reporting Person was granted five-year options to purchase an aggregate of 350,000 shares of the Company's Common Stock vesting 25% on the date of grant and 25% on each anniversary of the grant. /s/ ROBERT WEINGARTEN 2020-08-20